The reactions of jade-green Tp*MoIVO(S2PR2) [Tp* = hydrotris(3,5-dimethylpyrazol-1-yl)borate; R = Et, Pri, Ph] with propylene sulfide produce ochre-red Tp*MoVIOS{SP(S)R2}. The complexes have been characterized by microanalysis, mass spectrometry, cyclic voltammetry, spectroscopy (IR, NMR, UV-vis, and X-ray absorption), and X-ray crystallography. The distorted-octahedral isopropyl and phenyl derivatives feature a tridentate fac-Tp* ligand, a terminal oxo ligand, and a unique five-membered Mo(=S){SP(=S)R2 ring moiety formed by a weak, intramolecular, bonding interaction between the Mo=S1 and (uncoordinated) S3=P moieties. The Mo=S1 [2.227(2) A (R = Pri) and 2.200(2) A (R = Ph)] and S1...S3 distances [2.396(3) A (R = Pri) and 2.383(2) A (R = Ph)] are indicative of a pi-bonded Mo=S1 unit and a weak (bond order ca. 1/3) S1...S3 interaction; the solid-state structures are maintained in solution according to S K-edge X-ray absorption data. The complexes react with excess cyanide to form thiocyanate and Tp*MoO(S2PR2), under anaerobic conditions, or Tp*MoO2(S2PR2), under aerobic conditions; the latter models the production of thiocyanate and desulfo molybdenum hydroxylases upon cyanolysis of molybdenum hydroxylases. The complexes react with triphenylphosphine to give Tp*MoO(S2PR2) and SPPh3, with cobaltocene or hydrosulfide ion to produce [Tp*MoVOS(S2PR2)]-, and with ferrocenium salts to yield [Tp*MoVO(S3PR2)]+; in the last two reactions, Mo(V) is produced by direct or induced internal redox reactions, respectively. The presence of the Mo(O)=S...S interaction does not radically lengthen the Mo=S bond in the complexes or preclude them from reactions typical of unperturbed oxosulfidomolybdenum(VI) complexes.

Download full-text PDF

Source
http://dx.doi.org/10.1021/ic061213dDOI Listing

Publication Analysis

Top Keywords

moo=ss interaction
8
x-ray absorption
8
complexes react
8
molybdenum hydroxylases
8
complexes
6
synthesis characterization
4
characterization biomimetic
4
biomimetic chemistry
4
chemistry cis-oxosulfidomolybdenumvi
4
cis-oxosulfidomolybdenumvi complexes
4

Similar Publications

Background: This study aimed to develop a risk-scoring model for hypertension among Africans.

Methods: In this study, 4413 stroke-free controls were used to develop the risk-scoring model for hypertension. Logistic regression models were applied to 13 risk factors.

View Article and Find Full Text PDF

Chemical, Pharmacological, and Structural Characterization of Novel Acrylamide-Derived Modulators of the GABA Receptor.

Mol Pharmacol

September 2023

Department of Pharmacology and Physiology, Oklahoma State University College of Osteopathic Medicine, Tahlequah, Oklahoma (H.R.A.); Department of Anesthesiology, Washington University School of Medicine, St. Louis, Missouri (S.R.P., A.L.G., S.Q.X., G.A.); Facultad de Medicina, Universidad de Morón, Morón, and CONICET, Argentina (M.O.O.); Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Kyoto, Japan (S.S., I.H.); Department of Neurosciences, Psychology, Drug Research and Child Health Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Florence, Italy (D.M., M.N.R.); The Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St. Louis, Missouri (G.A.).

Acrylamide-derived compounds have been previously shown to act as modulators of members of the Cys-loop transmitter-gated ion channel family, including the mammalian GABA receptor. Here we have synthesized and functionally characterized the GABAergic effects of a series of novel compounds (termed "DM compounds") derived from the previously characterized GABA and the nicotinic 7 receptor modulator (E)-3-furan-2-yl--p-tolyl-acrylamide (PAM-2). Fluorescence imaging studies indicated that the DM compounds increase apparent affinity to the transmitter by up to 80-fold in the ternary GABA receptor.

View Article and Find Full Text PDF
Article Synopsis
  • Dapagliflozin has shown to improve heart failure and kidney-related outcomes in patients with type 2 diabetes, particularly in those with or at high risk for cardiovascular disease, as demonstrated in the DECLARE-TIMI 58 trial.
  • The trial involved 17,160 patients and assessed the medication's effects based on different levels of baseline systolic blood pressure (SBP) while monitoring both efficacy outcomes (like hospitalization for heart failure) and safety outcomes (like acute kidney injury).
  • Results indicated that dapagliflozin decreased SBP and its benefits for heart and kidney health were consistent across various BP categories, with no serious safety issues related to the drug compared to placebo.
View Article and Find Full Text PDF

An aerial humidity-induced solid-phase hydrolytic transformation of the [Zn(NH)]MoO2HO (compound 2HO) with the formation of [(NH)HZn(OH)(MoO)] (x = 0.92-0.94) coordination polymer (formally NHZn(OH)MoO, compound ) is described.

View Article and Find Full Text PDF

The reactions of jade-green Tp*MoIVO(S2PR2) [Tp* = hydrotris(3,5-dimethylpyrazol-1-yl)borate; R = Et, Pri, Ph] with propylene sulfide produce ochre-red Tp*MoVIOS{SP(S)R2}. The complexes have been characterized by microanalysis, mass spectrometry, cyclic voltammetry, spectroscopy (IR, NMR, UV-vis, and X-ray absorption), and X-ray crystallography. The distorted-octahedral isopropyl and phenyl derivatives feature a tridentate fac-Tp* ligand, a terminal oxo ligand, and a unique five-membered Mo(=S){SP(=S)R2 ring moiety formed by a weak, intramolecular, bonding interaction between the Mo=S1 and (uncoordinated) S3=P moieties.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!